- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Severe Nonproliferative
Total 3803 results
-
Daewoong Pharmaceutical Co. LTD.Completed
-
Galderma R&DCompletedModerate to Severe Glabellar LinesChina
-
AMIpharm Co., Ltd.CompletedModerate or Severe Submental FullnessKorea, Republic of
-
EuBiologics Co.,LtdCompletedModerate to Severe Glabellar LinesKorea, Republic of
-
AllerganCompletedModerate to Severe Nasolabial FoldsGermany, Netherlands
-
Derming SRLCompletedModerate-severe Skin Aging/Photoaging
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessAustralia, Canada, United Kingdom
-
Kythera BiopharmaceuticalsCompletedModerate or Severe Submental FullnessUnited States
-
Kythera BiopharmaceuticalsBayerCompletedModerate or Severe Submental FullnessBelgium, France, Germany, Italy, Spain, United Kingdom
-
University of OxfordLondon School of Hygiene and Tropical Medicine; University College, London; KEMRI-Wellcome... and other collaboratorsUnknownAntibiotic Resistance | Malnutrition Severe | Antibiotic ToxicityKenya, Uganda
-
Victor M. AguayoGandhi Medical College, Bhopal; Bundelkhand Medical College, Sagar, Madhya... and other collaboratorsCompletedSevere MalnutritionIndia
-
Bernhard Nocht Institute for Tropical MedicineInstitut National de la Santé Et de la Recherche Médicale, France; University... and other collaboratorsCompleted
-
National Institute of Allergy and Infectious Diseases...The Emmes Company, LLC; US Military HIV Research ProgramCompletedHemorrhagic Fever, EbolaUganda
-
Universitätsklinikum Hamburg-EppendorfUniversity Hospital, Geneva; Wellcome Trust; KEMRI-Wellcome Trust Collaborative... and other collaboratorsCompletedHemorrhagic Fever, EbolaGermany
-
Merz Aesthetics GmbHMerz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Germany
-
Croma-Pharma GmbHActive, not recruitingModerate to Severe Midface Volume DeficitUnited States
-
Major Extremity Trauma Research ConsortiumCompletedSevere Distal Tibia Injury | Severe Ankle Injury | Severe Foot Injury | Major Soft Tissue Loss | Major Bone Articular Surface Loss | Major Ankle Articular Surface LossUnited States
-
Janssen Vaccines & Prevention B.V.Bavarian Nordic GmbHTerminatedHemorrhagic Fever, EbolaFrance, United Kingdom, Kenya, United States, Uganda, Burkina Faso, Tanzania
-
Janssen Vaccines & Prevention B.V.Walter Reed Army Institute of Research (WRAIR)CompletedHemorrhagic Fever, EbolaUnited States, Uganda, Kenya, Mozambique, Nigeria, Tanzania
-
Centers for Disease Control and PreventionDepartment of Health and Human Services; University of Sierra Leone; Ministry... and other collaboratorsCompletedHemorrhagic Fever, EbolaSierra Leone
-
Ridgeback Biotherapeutics, LPInstitut National de Recherche Biomédicale. Kinshasa, République Démocratique...AvailableHemorrhagic Fever, EbolaCongo, The Democratic Republic of the, Sierra Leone
-
Gamaleya Research Institute of Epidemiology and...CompletedHemorrhagic Fever, EbolaRussian Federation
-
Assistance Publique - Hôpitaux de ParisIncyte CorporationRecruitingAdults Patients Having Non Severe HLHFrance
-
University of Colorado, DenverOpenBiomeWithdrawnSevere Motility Disorder
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States
-
Merz North America, Inc.CompletedModerate to Severe Midface Volume DeficitCanada
-
Merz Pharmaceuticals GmbHCompletedModerate to Severe Glabellar Frown LinesUnited States, Canada
-
Mahidol UniversityCompletedLimbal Deficiency | Severe Ocular Surface DamageThailand
-
LG Life SciencesCompletedNormal, Healthy Adults With Moderate, Severe, or Very Severe Volume Loss of Anteromedial Malar Region Who Have Completed the LG-HACL014 StudyKorea, Republic of
-
The Immunobiological Technology Institute (Bio-Manguinhos)...Wellcome TrustUnknownYellow Fever VaccineBrazil
-
The Immunobiological Technology Institute (Bio-Manguinhos)...Completed
-
Beckman Coulter, Inc.Biomedical Advanced Research and Development AuthorityEnrolling by invitationSevere Sepsis | Severe Sepsis Without Septic ShockUnited States
-
Sanofi Pasteur, a Sanofi CompanyActive, not recruitingYellow Fever (Healthy Volunteers)United States
-
Emory UniversityNational Institute of Allergy and Infectious Diseases (NIAID)Enrolling by invitationYellow Fever VaccineUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
Association for Innovation and Biomedical Research...CompletedType 2 Diabetes Mellitus | Mild Nonproliferative Diabetic RetinopathyPortugal, India
-
The Immunobiological Technology Institute (Bio-Manguinhos)...Ministry of Health, BrazilActive, not recruitingImmunity | Yellow Fever VaccineBrazil
-
Rennes University HospitalUnknownSevere Sepsis or Septic Shock
-
Ilocos Training and Regional Medical CenterNot yet recruitingDengue Fever With Warning Signs
-
US Army Medical Research Institute of Infectious...CompletedYellow Fever Vaccination ReactionUnited States
-
Sanofi Pasteur, a Sanofi CompanyCompletedYellow Fever (Healthy Volunteers)United States
-
Sarepta Therapeutics, Inc.United States Department of DefenseCompletedMarburg Hemorrhagic FeverUnited States
-
Assistance Publique - Hôpitaux de ParisCompletedSevere Septic Syndrome (Severe Sepsis and Septic Shock) Diagnosed and Treated by Mobile Intensive Care UnitFrance
-
AllerganCompletedPatients With Moderate to Severe Perioral LinesUnited States
-
University of California, San FranciscoCompletedClinically Severe ObesityUnited States
-
International Centre for Diarrhoeal Disease Research...CompletedSevere Acute Malnutrition | Severe Wasting | Community Based Nutritional ManagementBangladesh
-
Janssen Vaccines & Prevention B.V.Institut National de la Santé Et de la Recherche Médicale, France; Centre Muraz and other collaboratorsCompletedHemorrhagic Fever, EbolaKenya, Uganda, Burkina Faso, Côte D'Ivoire
-
Sarepta Therapeutics, Inc.United States Department of DefenseCompletedMarburg Hemorrhagic FeverUnited States
-
U.S. Army Medical Research and Development CommandBausch Health Americas, Inc.WithdrawnCrimean-Congo Hemorrhagic Fever | Lassa FeverGermany
-
Astellas Pharma Europe Ltd.CompletedModerate to Severe Vasomotor SymptomsUnited Kingdom